GlycoNex Incorporation (TPEX:4168)
Taiwan · Delayed Price · Currency is TWD 22.05
0.00 (0.00%)
Jul 30, 2026, 1:24 PM CST
GlycoNex Incorporation Market Cap
GlycoNex Incorporation has a market cap or net worth of 2.48 billion as of July 29, 2026. Its market cap has decreased by -5.45% in one year.
Market Cap
2.48B
Enterprise Value
2.34B
Revenue
36.35M
Ranking
n/a
PE Ratio
n/a
Stock Price
22.05
ChartMarket Cap Chart
Since December 16, 2011, GlycoNex Incorporation's market cap has increased from 1.51B to 2.48B, an increase of 64.58%. That is a compound annual growth rate of 3.47%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 28, 2026 | 2.57B | -7.73% |
| Dec 31, 2025 | 2.79B | 2.79% |
| Dec 31, 2024 | 2.71B | -16.13% |
| Dec 29, 2023 | 3.23B | -0.89% |
| Dec 30, 2022 | 3.26B | 13.02% |
| Dec 30, 2021 | 2.89B | 3.11% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| 3D Global Biotech | 3.09B |
| Energenesis Biomedical CO.,LTD. | 2.80B |
| Intech Biopharm | 2.76B |
| BRIM Biotechnology | 2.75B |
| Great Novel Therapeutics Biotech & Medicals | 2.62B |
| Chunghwa Chemical Synthesis & Biotech | 2.50B |
| Syngen Biotech | 2.39B |
| Taiwan Bio Therapeutics | 2.19B |